Report Highlights
The global market for synthetic biology is expected to increase from $35.5 billion in 2023 to $59.2 billion by the end of 2028, with a compound annual growth rate (CAGR) of 10.8% during the forecast period of 2023-2028.
Report Includes
- 141 data tables and 33 additional tables
- An overview of the top 10 suppliers of synthetic biology technology and the global market
- Analysis of global market trends, featuring historical revenue data for 2020-2022, estimated figures for 2023, forecasts for 2028, and projections of compound annual growth rates (CAGRs) through 2028
- Evaluation of the current market size and revenue growth prospects specific to synthetic biology technology, accompanied by a market share analysis by test type, industry and geographic region
- Coverage of evolving technologies, the current and future market potential, and the regulatory framework and reimbursement scenarios
- Review of patents, the product pipeline and ESG trends related to the synthetic biology industry
- Market share analysis of the key companies and coverage of mergers & acquisitions, joint ventures, collaborations, partnerships and other market strategies
- Company profiles of major players within the industry, including Amyris Inc., Beyond Meat Inc., GenScript, Ginkgo Bioworks, Novozymes A/S, and Twist Biosciences.
Report Scope
The report is designed to be a comprehensive business tool to report focuses on 10 selected synthetic biology companies and the key areas in the field driving the industry growth that allows these companies to succeed.
The market is divided into segments and by application/industry as follows:
By product:
- Enabling Products.
- Biologic Components.
- Integrated systems
- Enabled Products.
By Industry:
- R&D Tools.
- Diagnostics/Pharmaceuticals.
- Agriculture.
- Chemicals.
- Energy.
- Food & Beverages.
- Others.
Each area is covered in detail, identifying current products in the market in the base year 2022, measuring current market size and identifying current and potential market drivers, forecasting for 2028, assessing current and potential competitors, and identifying current competitor market shares for the base year of 2022.
Report Synopsis
| Report Metrics | Details | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Base year considered | 2022 | ||||||||||||||
| Forecast period considered | 2023-2028 | ||||||||||||||
| Base year market size | $31.5 billion | ||||||||||||||
| Market size forecast | $59.2 billion | ||||||||||||||
| Growth rate | CAGR of 10.8% for the forecast period of 2023-2028 | ||||||||||||||
| Units considered | $ Millions | ||||||||||||||
| Segments covered | Region, Product Type, Industry | ||||||||||||||
| Regions covered | North America, Europe, Asia-Pacific, Latin America, Rest of the World (RoW) | ||||||||||||||
| Countries covered | U.S., Mexico, Canada, Germany, France, U.K., Italy, Spain, Japan, China, India, Brazil, Argentina, Chile, Middle East, Africa, South America, Switzerland, Denmark, Norway, Poland, Belgium, Austria, Netherlands, Sweden, Russia, Australia, New Zealand, Taiwan, Singapore, Malaysia, Thailand, Philippines, Indonesia | ||||||||||||||
| Key Market Drivers |
|
||||||||||||||
| Companies studied |
|
Frequently Asked Questions (FAQs)
Analyst Credentials
Gundreddy Gopinadh– Associate Consultant-Life Sciences Research
Gopinadh is an experienced professional with nearly nine years in the market research industry and experience in research and analysis, specializing in medical devices, pharmaceuticals, biotechnology, and in-vitro diagnostics verticals. He is an expert in handling custom projects by gathering data points, analyzing market trends, and ultimately providing clients with accurate market size numbers, actionable insights, and recommendations based on their unique business needs. Academically, Gopinadh holds a master’s degree in biotechnology from VIT University.
Report Highlights
Report Includes
- Identification of the top 10 companies in the market for synthetic biology technology, and the rationale behind these selections.
- Factors taken into account, including technical innovation, market leadership, and commitment to this market via investment in products.
When selecting these top 10 companies, BCC Research looked across the industry spectrum and selected the most active and significant contributors while recognizing that there are many other contenders. Some of these “significant others” are included but to a less detailed extent than the top 10 companies.
Related Reports
DNA Data Storage: Global Markets and Technologies
The global DNA data storage market should reach $1.5 billion by 2027 from $105.5 million in 2022 at a compound annual growth rate (CAGR) of 69.8% for the forecast period of 2022 to 2027.
Synthetic Biology: Global Markets
The global market for synthetic biology is estimated to increase from $9.5 billion in 2021 to $33.2 billion by 2026, at a compound annual growth rate (CAGR) of 28.4% during the forecast period of 2021-2026.
Global DNA Read, Write and Edit Market
The global market for DNA read, write and edit applications should grow from $17.0 billion in 2019 to $43.1 billion by 2024 with a compound annual growth rate (CAGR) of 20.5% during the period of 2019-2024.
Recent Reports
Life Science Tools and Reagents: Global Markets
The global market for life science tools and reagents, including COVID-19 diagnostics was valued at $59.4 billion in 2023. This market is expected to grow from $53.2 billion in 2024 to reach $66.5 billion by the end of 2029, at a CAGR of 4.6% during the forecast period of 2024-2029.
RNAi Technologies and Global Markets
The global market for RNAi technology is estimated to increase from $2.1 billion in 2023 to reach $4.8 billion by 2029, at a compound annual growth rate (CAGR) of 14.8% from 2024 through 2029.
Metabolomics: Technologies and Global Markets
The global market for metabolomics technologies is expected to grow from $16.4 billion in 2024 and is projected to reach $30.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 13.1% during the forecast period of 2024 to 2029.
Global Recombinant Proteins Market
The global market for recombinant proteins is estimated to increase from $132.4 billion in 2023 to reach $203.6 billion by 2029, at a compound annual growth rate (CAGR) of 7.5% from 2024 through 2029.
Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics
The global market for polymerase chain reaction for point-of-care diagnostics is expected to grow from $1.6 billion in 2024 to $2.1 billion by the end of 2029, at a compound annual growth rate (CAGR) of 5.9% from 2024 through 2029.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More